Most recent
ISO 10993-3:2026
Biological evaluation of medical devices - Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity
This document specifies strategies for risk estimation and evaluation of biological harms with respect to:
- genotoxicity;
- carcinogenicity;
- reproductive toxicity; and
- developmental toxicity.
This document is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity has been established.
This document is not applicable to active pharmaceutical ingredients of device-drug combination products or biological components of device-biologic combination products which are covered by regulations.
NOTE Guidance on selecting relevant biological effects for medical devices is covered in ISO 10993-1.
- ADD TO ALERT |
- PDF |
International Organization for Standardization [iso]